Xofluza

A unique feature about XOFLUZA, compared to neuroaminidase inhibitors like Tamiflu and Relenza, is that you only have to take a single dose. Not multiple doses for multiple days - Bruce Y. Lee

Xofluza
Xofluza

image by: CureMed Pharmacy

HWN Recommends

The FDA just approved the first new flu drug in 20 years. Here’s what you need to know

Our arsenal in the endless, roving, ever-evolving battle against the influenza virus just got slightly larger. The Food & Drug Administration just announced that they had approved the aptly-named Xofluza, the first new antiviral drug in two decades, to help alleviate the symptoms of a flu infection.

Last year roughly 80,000 people died of the flu, many of them from complications that antivirals can help fight. But antivirals, Xofluza included, aren’t for everyone—here’s what you need to know as we head into this year’s flu season.

Is this drug any different from Tamiflu?

The reason Xofluza got…

read full article

Resources

 The FDA just approved the first new flu drug in 20 years. Here’s what you need to know

Xofluza can help thousands of people this flu season, but it's not for everyone.

Xofluza

XOFLUZA is approved for treatment and post-exposure prophylaxis of the flu in otherwise healthy patients aged ≥5 years.

CDC

Baloxavir works differently than the other currently recommended flu antiviral drugs, which are neuraminidase inhibitors (oseltamivir, zanamivr and peramivir).

Introducing Stitches!

Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!

Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.


Be the first to know when Stitches starts accepting users


Stay Connected